US Patent Issued to Bolt Biotherapeutics on June 10 for "Anti-Dectin-2 antibodies and methods of using" (California Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,750, issued on June 10, was assigned to Bolt Biotherapeutics Inc. (Redwood City, Calif.).

"Anti-Dectin-2 antibodies and methods of using" was invented by Shelley Erin Ackerman (Redwood City, Calif.), David Dornan (Redwood City, Calif.), Karla A. Henning (Redwood City, Calif.) and Justin A. Kenkel (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to dendritic cell-associated C-type lectin 2 (Dectin-2) binding agents, nucleic acids comprising the inventive binding agents, vectors and cells comprising the inventive nucleic acids, and compositions thereof. The invention also relates to methods of providing the in...